Live Breaking News & Updates on Eyepoint Pharmaceuticals

Stay updated with breaking news from Eyepoint pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Monashee Investment Management LLC Takes $4.04 Million Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT)

Monashee Investment Management LLC bought a new stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Free Report) in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 175,000 shares of the company’s stock, valued at approximately $4,044,000. EyePoint Pharmaceuticals accounts for about 0.7% of Monashee […] ....

Robertw Baird , Davidr Guyer , Securities Exchange Commission , Quarter For Eyepoint Pharmaceuticals , Investment Advisers , Deutsche Bank , Eyepoint Pharmaceuticals Company Profile , China Universal Asset Management Co , Eyepoint Pharmaceuticals , Eyepoint Pharmaceuticals Inc , Mirae Asset Global Investments Co , News Ratings For Eyepoint Pharmaceuticals Daily , Monashee Investment Management , Eyepoint Pharmaceuticals Stock Performance , Toth Financial Advisory Corp , Insider Activity At Eyepoint Pharmaceuticals , Free Report , Point Pharmaceuticals , Investment Management , Asset Global Investments , Financial Advisory Corp , China Universal Asset Management , Director David , Exchange Commission , Cormorant Asset Management , One Financial ,

ARVO 2024: Possible link between long COVID, vision changes tops Healio's written items

ARVO 2024: Possible link between long COVID, vision changes tops Healio's written items
healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.

Association For Research , Eyepoint Pharmaceuticals ,

EyePoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down to $11.16

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT – Get Free Report)’s stock price gapped down prior to trading on Tuesday . The stock had previously closed at $11.16, but opened at $10.90. EyePoint Pharmaceuticals shares last traded at $11.13, with a volume of 79,034 shares. Analyst Ratings Changes Several research analysts have recently issued reports on the company. […] ....

Davidr Guyer , Robertw Baird , Institutional Trading Of Eyepoint Pharmaceuticals , Securities Exchange Commission , Eyepoint Pharmaceuticals Inc , Eyepoint Pharmaceuticals Company Profile , Mirae Asset Global Investments Co , Eyepoint Pharmaceuticals Stock , News Ratings For Eyepoint Pharmaceuticals Daily , Deutsche Bank , Investment Advisers , Eyepoint Pharmaceuticals , Tower Research Capital , Ameritas Investment Partners Inc , Get Free Report , Point Pharmaceuticals , One Financial , Director David , Cormorant Asset Management , Exchange Commission , Asset Global Investments , Investment Partners , Research Capital , Eyepoint Pharmaceuticals Daily ,

Uveitis Treatment Market and Competitive Landscape Report,

Dublin, May 16, 2024 (GLOBE NEWSWIRE) The ....

United States , Asia Pacific , Alimera Sciences , Bausch Health , Eyepoint Pharmaceuticals , Drug Stores Retail Pharmacies , List Of Uveitis Treatment Companies , Porter Five , Treatment Market Report , Competitive Analysis , Treatment Market , Drug Class , Disease Type , Distribution Channel , Uveitis Treatment , Size Estimates , Forecast Analysis , North America , Five Forces ,

EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Macau General , Hong Kong , Amy Phillips , Christina Tartaglia , Eyepoint Pharmaceuticals Nasdaq , Eyepoint Pharmaceuticals , Equinox Sciences , Eyepoint Pharmaceuticals Inc , Green Room Communications , Betta Pharmaceuticals , Compensation Committee , Point Pharmaceuticals , Term Incentive Plan , Eyepoint Pharmaceutical , Ihr Portfolio ,